SCHEMBL4499513

SCHEMBL4499513

CN(C)CCN(C(=O)c1ccccc1)c1ccc(NC(=C2C(=O)Nc3cc(F)ccc32)c2ccccc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 2/20 0.41
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
FLT3 P36888 3/20 0.37
MAPT P10636 3/20 0.37
RECQL P46063 2/20 0.37
ALDH1A1 P00352 1/20 0.36
ADRB2 P07550 1/20 0.36
HPGD P15428 1/20 0.36
PDGFRB P09619 2/20 0.36
TGM2 P21980 1/20 0.34
NR3C2 P08235 1/20 0.34
TP53 P04637 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
AURKA O14965 1/20 0.34
PDGFRA P16234 1/20 0.34
KDR P35968 1/20 0.34
AURKB Q96GD4 1/20 0.34
AURKC Q9UQB9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4499508 1.00 BACE1 (0.41) BACE1MEN1KMT2AFLT3MAPT
SCHEMBL4495013 0.95 BACE1 (0.37) BACE1MEN1KMT2AFLT3MAPT
SCHEMBL4495018 0.95 BACE1 (0.37) BACE1MEN1KMT2AFLT3MAPT
SCHEMBL4494303 0.93 BACE1 (0.41) BACE1FLT3MAPTALDH1A1HPGD
SCHEMBL6182458 0.93 BACE1 (0.41) BACE1FLT3MAPTALDH1A1HPGD
SCHEMBL4494308 0.93 BACE1 (0.41) BACE1FLT3MAPTALDH1A1HPGD
SCHEMBL4495891 0.92 HTT (0.40) BACE1MEN1KMT2AFLT3MAPT
SCHEMBL4495890 0.92 HTT (0.40) BACE1MEN1KMT2AFLT3MAPT
SCHEMBL4498295 0.92 BACE1 (0.38) BACE1FLT3MAPTPDGFRBTGM2
SCHEMBL4498293 0.92 BACE1 (0.38) BACE1FLT3MAPTPDGFRBTGM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514468-B2 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2009-04-07 US disclosed
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2006-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions KDR, FLT1, EGFR BACE1 1615/4885MEN1 1288/4885KMT2A 3530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.